•
Mar 31, 2024
•
/

Ascendis Pharma Q1 2024 Earnings Report

Total Revenue
€96.3M
Previous year: €32.6M
+194.9%
EPS
-€2.31
Previous year: -€1.93
+19.9%
Basic and diluted EPS
-€2.3
Shares outstanding
56.88M
Gross Profit
€85M
Cash and Equivalents
€320M
Free Cash Flow
-€102M
Total Assets
€802M

Ascendis Pharma

Ascendis Pharma

Ascendis Pharma Revenue by Segment

Revenue & Expenses

Visualization of income flow from segment revenue to net income